TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T09921 XX ID T09921 XX DT 18.01.2006 (created); anu. DT 20.05.2014 (updated); asv. CO Copyright (C), QIAGEN. XX FA c-Myb XX SY c-Myb; MYB; MYB PROTO-ONCOGENE PROTEIN. XX OS mouse, Mus musculus OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae XX GE G000488 Myb. XX CL C0022; trp; 3.5.1.1.1.1. XX SZ 636 AA; 71.4 kDa (cDNA) (calc.), 75 kDa (SDS) XX SQ MARRPRHSIYSSDEDDEDIEMCDHDYDGLLPKSGKRHLGKTRWTREEDEKLKKLVEQNGT SQ DDWKVIANYLPNRTDVQCQHRWQKVLNPELIKGPWTKEEDQRVIELVQKYGPKRWSVIAK SQ HLKGRIGKQCRERWHNHLNPEVKKTSWTEEEDRIIYQAHKRLGNRWAEIAKLLPGRTDNA SQ IKNHWNSTMRRKVEQEGYLQEPSKASQTPVATSFQKNNHLMGFGHASPPSQLSPSGQSSV SQ NSEYPYYHIAEAQNISSHVPYPVALHVNIVNVPQPAAAAIQRHYNDEDPEKEKRIKELEL SQ LLMSTENELKGQQALPTQNHTCSYPGWHSTSIVDQTRPHGDSAPVSCLGEHHATPSLPAD SQ PGSLPEESASPARCMIVHQGTILDNVKNLLEFAETLQFIDSFLNTSSNHESSGLDAPTLP SQ STPLIGHKLTPCRDQTVKTQKENSIFRTPAIKRSILESSPRTPTPFKHALAAQEIKYGPL SQ KMLPQTPSHAVEDLQDVIKRESDESGIVAEFQESGPPLLKKIKQEVESPTEKSGNFFCSN SQ HWAENSLSTQLFSQASPVADAPNILTSSVLMTPVSEDEDNVLKAFTVPKNRPLVGPLQPC SQ SGAWEPASCGKTEDQMTASGPARKYVNAFSARTLVM XX SC translated from EMBL:BC011513 XX FT 35 86 PS50090; MYB_3. FT 39 88 SM00717; sant. FT 40 86 PF00249; Myb-like DNA-binding domain. FT 56 582 PF00478; IMP dehydrogenase / GMP reductase dom. FT 87 138 PS50090; MYB_3. FT 91 140 SM00717; sant. FT 92 138 PF00249; Myb-like DNA-binding domain. FT 139 189 PS50090; MYB_3. FT 143 191 SM00717; sant. FT 144 189 PF00249; Myb-like DNA-binding domain. FT 223 313 PF07988; Mitotic protein Wos2. FT 275 325 transcription activation domain [4]. XX IN T00581 C/EBPbeta; human, Homo sapiens. IN T00526 MyoD; mouse, Mus musculus. XX MX M00004 V$CMYB_01. MX M01821 V$CMYB_Q5. MX M02883 V$MYB_03. MX M02779 V$MYB_05. MX M00773 V$MYB_Q3. MX M07299 V$MYB_Q4. MX M00913 V$MYB_Q5_01. MX M08890 V$MYB_Q5_02. MX M00183 V$MYB_Q6. XX BS R32837. BS R02100. BS R02392. BS R31102. BS R29667. BS R01431. BS R21711. BS R21712. BS R21713. BS R21714. BS R21719. BS R21723. BS R03999. BS R04000. BS R04001. BS R04002. BS R08124. BS R38135. BS R38136. BS R61902. BS R20714. BS R01849. XX DR TRANSPATH: MO000057321. DR EMBL: BC011513; DR EMBL: K03547; DR EMBL: M12848; DR EMBL: M13989; DR EMBL: M20210; DR EMBL: M21169; DR EMBL: X02774; DR EMBL: X04099; DR EMBL: X04100; DR EMBL: X04101; DR EMBL: X04102; DR EMBL: X04103; DR EMBL: X04104; DR EMBL: X16389; DR EMBL: X16390; DR UniProtKB: P06876; DR PDB: 1IDY. DR PDB: 1IDZ. DR PDB: 1MBE. DR PDB: 1MBF. DR PDB: 1MBG. DR PDB: 1MBH. DR PDB: 1MBJ. DR PDB: 1MBK. DR PDB: 1MSE. DR PDB: 1MSF. XX RN [1]; RE0047992. RX PUBMED: 11792321. RA Tahirov T. H., Sato K., Ichikawa-Iwata E., Sasaki M., Inoue-Bungo T., Shiina M., Kimura K., Takata S., Fujikawa A., Morii H., Kumasaka T., Yamamoto M., Ishii S., Ogata K. RT Mechanism of c-Myb-C/EBP beta cooperation from separated sites on a promoter. RL Cell 108:57-70 (2002). RN [2]; RE0048003. RX PUBMED: 9566892. RA Hedge S. P., Kumar A., Kurschner C., Shapiro L. H. RT c-Maf interacts with c-Myb to regulate transcription of an early myeloid gene during differentiation. RL Mol. Cell. Biol. 18:2729-2737 (1998). RN [3]; RE0048027. RX PUBMED: 16055116. RA Kaspar P., Pajer P., Sedlak D., Tamaoki T., Dvorak M. RT c-Myb inhibits myogenic differentiation through repression of MyoD. RL Exp. Cell Res. 309:419-428 (2005). RN [4]; RE0002390. RX PUBMED: 2668947. RA Sakura H., Kanei-Ishii C., Nagase T., Nakagoshi H., Gonda T. J. RT Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene RL Proc. Natl. Acad. Sci. USA 86:5758-5762 (1989). XX //